Publication | Closed Access

Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation

ThrombosisCardiovascular DiseaseStrokePharmacologyCardiovascular PharmacologyXimelagatran Versus WarfarinFibrinolysisPharmacotherapyMedicineAnticoagulantCardiology